Search results
Author(s):
Atsushi Sakamoto
,
Anne Cornelissen
,
Yu Sato
,
et al
Added:
2 years ago
Author(s):
Stéphane G Carlier
,
Kaoru Tanaka
,
Amin Katouzian
Added:
3 years ago
Most cases of myocardial infarction and stroke occur when a thrombus is formed on a previously stable plaque that ruptures.1 Persons at risk typically have no premonitory symptoms, and angiographic studies of coronary arteries in patients with non-fatal acute coronary syndromes (ACS) showed that most such events are due to rapid progression of mild, hemodynamically insignificant lesions.2–4…
View more
Author(s):
Xiao-Fei Gao
,
Xiang-Quan Kong
,
Guang-Feng Zuo
,
et al
Added:
3 years ago
Coronary angiography is widely used to diagnose coronary artery disease and to guide percutaneous coronary intervention (PCI). However, 2D projection angiography cannot completely reflect the 3D coronary lumen, with several inherent limitations in evaluating plaque composition, vessel diameter, diffuse reference vessel disease, lesion severity, as well as the result of stent deployment. In the…
View more
Author(s):
Marc Sirol
Added:
3 years ago
Atherosclerosis and its thrombotic complications are the first cause of mortality and morbidity in industrialized countries. Furthermore, despite pharmacological intervention and lifestyle changes, cardiovascular disease (CVD) continues to be the principal cause of death in the US. Despite great advances in the understanding of the initiation and progression of atherosclerosis and its risk…
View more
Author(s):
Annapoorna Kini
Added:
1 year ago
ACC.23/WCC — Principle investigator of YELLOW III, Dr Annapoorna Subhash Kini(Mount Sinai Hospital, US) joins us to talk about the study that assessed the effect of evolocumab (Repatha) on coronary plaque morphology using intravascular imaging and gene expression analysis of peripheral blood mononuclear cells (PBMC) in 140 patients with stable CAD on maximally tolerated statin therapy …
View more
Author(s):
Gregory Petrossian
,
Denizhan Ozdemir
,
Keyvan Karimi Galougahi
,
et al
Added:
1 year ago
Author(s):
Marc Sirol
Added:
3 years ago
Atherosclerosis and its thrombotic complications are the first cause of mortality and morbidity in industrialized countries. Furthermore, despite pharmacological intervention and lifestyle changes, cardiovascular disease (CVD) continues to be the principal cause of death in the US.1 Despite great advances in the understanding of the initiation and progression of atherosclerosis and its risk…
View more
AF Symposium 2024 Late-Breaking Science Collection
Video Series
PCI for Chronic Total Occlusion
Author(s):
Giovanni Maria Vescovo
,
Carlo Zivelonghi
,
Benjamin Scott
,
et al
Added:
3 years ago
Article
Author(s):
Lorenz Räber
Added:
1 year ago
In this late-breaking interview focusing on the PACMAN-AMI Trial, Prof Lorenz Räber (Bern University Hospital, CH) reveals that the use of alirocumab reduced coronary plaque regression in patients with acute myocardial infarction (AMI) (NCT03067844).
Originally presented by Prof Raber at ACC.22, these findings suggest that alirocumab, on top of high-intensity statin therapy, may be an effective…
View more